Loading...

Ahmed Abdelhak, MD

Title(s)Postdoctoral Scholar, Neurology
SchoolSchool of Medicine
Address675 Nelson Rising Lane
San Francisco CA 94158
Phone--
ORCID ORCID Icon0000-0001-9731-4169 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis. Cells. 2020 Nov 25; 9(12). Robinson T, Abdelhak A, Bose T, Meinl E, Otto M, Zettl UK, Dersch R, Tumani H, Rauer S, Huss A. PMID: 33255854.
      View in: PubMed   Mentions:    Fields:    
    2. Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies. Biomedicines. 2020 Aug 28; 8(9). Huss A, Senel M, Abdelhak A, Mayer B, Kassubek J, Ludolph AC, Otto M, Tumani H. PMID: 32872144.
      View in: PubMed   Mentions:
    3. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2020 Aug 25. Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. PMID: 32840686.
      View in: PubMed   Mentions: 5     Fields:    
    4. A Score Based on NfL and Glial Markers May Differentiate Between Relapsing-Remitting and Progressive MS Course. Front Neurol. 2020; 11:608. Huss A, Otto M, Senel M, Ludolph AC, Abdelhak A, Tumani H. PMID: 32765393.
      View in: PubMed   Mentions:
    5. Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study. Contemp Clin Trials Commun. 2020 Jun; 18:100574. Abdelhak A, Huss A, Stahmann A, Senel M, Krumbholz M, Kowarik MC, Havla J, Kümpfel T, Kleiter I, Wüstinger I, Zettl UK, Schwartz M, Roesler R, Friede T, Ludolph AC, Ziemann U, Tumani H. PMID: 32478196.
      View in: PubMed   Mentions:
    6. Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker? Front Neurol. 2019; 10:280. Abdelhak A, Hottenrott T, Morenas-Rodríguez E, Suárez-Calvet M, Zettl UK, Haass C, Meuth SG, Rauer S, Otto M, Tumani H, Huss A. PMID: 30972011.
      View in: PubMed   Mentions:
    7. Serum GFAP as a biomarker for disease severity in multiple sclerosis. Sci Rep. 2018 10 04; 8(1):14798. Abdelhak A, Huss A, Kassubek J, Tumani H, Otto M. PMID: 30287870.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    8. Intrathecal immunoglobulin M production: A promising high-risk marker in clinically isolated syndrome patients. Ann Neurol. 2018 05; 83(5):1032-1036. Huss A, Abdelhak A, Halbgebauer S, Mayer B, Senel M, Otto M, Tumani H. PMID: 29665046.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    9. MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature. J Neuroinflammation. 2018 Mar 19; 15(1):88. Jarius S, Ruprecht K, Stellmann JP, Huss A, Ayzenberg I, Willing A, Trebst C, Pawlitzki M, Abdelhak A, Grüter T, Leypoldt F, Haas J, Kleiter I, Tumani H, Fechner K, Reindl M, Paul F, Wildemann B. PMID: 29554927.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    10. CSF profile in primary progressive multiple sclerosis: Re-exploring the basics. PLoS One. 2017; 12(8):e0182647. Abdelhak A, Hottenrott T, Mayer C, Hintereder G, Zettl UK, Stich O, Tumani H. PMID: 28797088.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Primary Progressive Multiple Sclerosis: Putting Together the Puzzle. Front Neurol. 2017; 8:234. Abdelhak A, Weber MS, Tumani H. PMID: 28620346.
      View in: PubMed   Mentions:
    12. Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis? Int J Mol Sci. 2015 Jul 31; 16(8):17565-88. Abdelhak A, Junker A, Brettschneider J, Kassubek J, Ludolph AC, Otto M, Tumani H. PMID: 26263977.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    Ahmed's Networks
    Concepts (34)
    Derived automatically from this person's publications.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑